FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1196.158

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1196.158
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.158/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158
Version20190829
Statusactive
Date2019-08-29T05:00:24-04:00
NameMultipleMyelomaRegimenDrugs
TitleMultiple Myeloma Regimen Drugs
Realmus
Authorityhl7
DescriptionAll drug components for the treatment of multiple myeloma across all regimens from NCCR 2019
Purpose(Clinical Focus: Multiple Myeloma chemo regimen drugs),(Data Element Scope: SCDGs only.),(Inclusion Criteria: All routed medication proxy for the specified regimen components (SCDG as a proxy for routed drug).),(Exclusion Criteria: None.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1196.158",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Elimu Informatics Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2019-08-29"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1196.158"
    }
  ],
  "version": "20190829",
  "name": "MultipleMyelomaRegimenDrugs",
  "title": "Multiple Myeloma Regimen Drugs",
  "status": "active",
  "experimental": false,
  "date": "2019-08-29T05:00:24-04:00",
  "publisher": "Elimu Informatics Steward",
  "description": "All drug components for the treatment of multiple myeloma across all regimens from NCCR 2019",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: Multiple Myeloma chemo  regimen drugs),(Data Element Scope: SCDGs only.),(Inclusion Criteria: All routed medication proxy for the specified regimen components (SCDG as a proxy for routed drug).),(Exclusion Criteria: None.)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "filter": [
          {
            "property": "concept",
            "op": "in",
            "value": "1154535,1154531"
          }
        ]
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "filter": [
          {
            "property": "concept",
            "op": "in",
            "value": "1154535,1154531,1163075,1156182,1160774,1302968,1721949,1160009,1726108,1369715"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:2be4f217-207d-4d64-b7de-8c6cc8ecd244",
    "timestamp": "2025-05-23T19:13:14-04:00",
    "total": 10,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1154531",
        "display": "dexamethasone Injectable Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1154535",
        "display": "dexamethasone Oral Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1156182",
        "display": "cyclophosphamide Oral Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1160009",
        "display": "bendamustine Injectable Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1160774",
        "display": "doxorubicin Injectable Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1163075",
        "display": "bortezomib Injectable Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1302968",
        "display": "carfilzomib Injectable Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1369715",
        "display": "pomalidomide Oral Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1721949",
        "display": "daratumumab Injectable Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1726108",
        "display": "elotuzumab Injectable Product"
      }
    ]
  }
}